Wuxi I·Campus: A hub of biomedical innovation, collaboration

Wuxi International Life-Science Innovation Campus (I•Campus) in Xinwu district, Wuxi. [Photo/WeChat account: xinwu_wx]

Wuxi International Life-Science Innovation Campus (I·Campus), located in the Wuxi National Hi-tech District, has been focusing on three key areas – pharmaceuticals and medical devices, special foods, and consumer healthcare. The park is currently home to more than 300 innovative enterprises.

To attract more projects, the park has sent delegations to visit European countries including France, Germany, and Belgium this year to engage with local universities, businesses, and industrial parks.

Due to these efforts, more than 30 technology companies set up operations in the park in the first half of this year. I·Campus has also begun cooperating with TusPark Belgium and Medical Valley in Nuremberg, Germany.

Notably, Cerba Research, the largest medical central laboratory in Europe, signed a partnership agreement with the park's Teddy Clinical Research Laboratory Wuxi. The two parties will jointly construct a world-class central laboratory which is expected to become a vital evidence-based medical hub for innovative drugs, vaccines, and diagnostic reagents in China.

I·Campus has also hosted a series of specialized forums, summits, and exhibitions to provide a platform for business connections among enterprises and further expand its global influence.

Construction of the second phase of I·Campus, covering an area of 200,000 square meters, is currently underway. Seven of the ten buildings have been already reserved. Additionally, a 100,000-sq-m third phase will start construction by the end of 2023.